Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 461915019 | Co-danthramer strong 500mg/37.5mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 714284010 | Co-danthramer strong 500mg/37.5mg capsule (substance) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1188125017 | Co-danthramer strong 500mg/37.5mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2572024013 | Dantron + poloxamer strong 37.5mg/500mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2576013013 | Dantron + poloxamer strong 37.5mg/500mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2576014019 | Co-danthramer strong 37.5mg/500mg capsule | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3483296018 | Product containing dantron 37.5 mg and poloxamer strong 500 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3492025011 | Dantron 37.5 mg and poloxamer strong 500 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3492026012 | Product containing dantron 37.5 mg and poloxamer strong 500 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3559506015 | Product containing only dantron 37.5 mg and poloxamer strong 500 mg/1 each oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3559507012 | Product containing only dantron 37.5 mg and poloxamer strong 500 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677947017 | Danthron 37.5 mg and poloxamer 188 500 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677948010 | Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677949019 | Dantron 37.5 mg and poloxamer 188 500 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3677950019 | Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing dantron and poloxamer 188 (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dantron | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Anthraquinone laxative (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Poloxamer 188 (substance) | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Poloxamer 188 (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Dantron | false | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 37.5 | false | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dantron | false | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Dantron | true | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 37.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Poloxamer 188 (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Poloxamer 188 (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Dantron- and poloxamer 188-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Poloxamer 188 (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Dantron | false | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Laxative therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Stool softener therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Dantron and poloxamer 188 only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Poloxamer 188 (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Dantron | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR